Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8395183 | Toxicon | 2015 | 7 Pages |
Abstract
CTX-I and CTX-II showed significant anticancer activity with minimum effects on normal cells and better IC50 compared to current anticancer drug; cisplatin. They induce their apoptotic effect via lysosomal pathways and release of cathepsins to cytosol. These effects were seen in limited rage of toxins concentrations and pattern of cell death rapidly changes to necrosis by increase in toxin's concentration. In conclusion, significant apoptogenic effects of these toxins candidate them as a possible anticancer agent.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Karim Ebrahim, Farshad H. Shirazi, Abbas Zare Mirakabadi, Hossein Vatanpour,